Ercan Muelduer
AuthID: R-00J-HH3
1
TITLE: Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma Full Text
AUTHORS: Katja Weisel; Meletios Dimopoulos; Philippe Moreau; Munci Yagci; Alessandra Larocca; Abraham S Kanate; Filiz Vural; Nicola Cascavilla; Supratik Basu; Peter Johnson; Peter Byeff; Marek Hus; Paula Rodriguez Otero; Ercan Muelduer; Pekka Anttila; Patrick J Hayden; Maria Theresa Krauth; Paulo Lucio; Dina Ben Yehuda; Larisa Mendeleeva; ...More
PUBLISHED: 2020, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 61, ISSUE: 8
AUTHORS: Katja Weisel; Meletios Dimopoulos; Philippe Moreau; Munci Yagci; Alessandra Larocca; Abraham S Kanate; Filiz Vural; Nicola Cascavilla; Supratik Basu; Peter Johnson; Peter Byeff; Marek Hus; Paula Rodriguez Otero; Ercan Muelduer; Pekka Anttila; Patrick J Hayden; Maria Theresa Krauth; Paulo Lucio; Dina Ben Yehuda; Larisa Mendeleeva; ...More
PUBLISHED: 2020, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 61, ISSUE: 8
INDEXED IN:
Scopus
WOS
![](/img/scopus_icon.png)
![](/img/clarivate-icon.png)